| Literature DB >> 25009367 |
Sundeep Jain1, Bharat Sharma2, Mitesh Kaushik1, Lokendra Jain1.
Abstract
Introduction and Objective. Bleeding is an important complication in liver transections. To determine the safety and efficacy of Debakey forceps for liver parenchymal transection and its ergonomic advantages over clamp crushing method we analysed our data. Methods. We used Debakey crushing technique in 100 liver resections and analysed data for transection time, transfusion rate, morbidity, mortality, hospital stay, influence of different types of liver conditions, and ergonomi features of Debakey forceps. Results. Mean age, transection time and hospital stay of 100 patients were 52.38 ± 17.44 years, 63.36 ± 33.4 minutes, and 10.27 ± 5.7 days. Transection time, and hospital stay in patients with cirrhotic liver (130.4 ± 44.4 mins, 14.6 ± 5.5 days) and cholestatic liver (75.8 ± 19.7 mins, 16.5 ± 5.1 days) were significantly greater than in patients with normal liver (48.1 ± 20.1 mins, 6.7 ± 1.8 days) (P < 0.01). Transection time improved significantly with experience (first fifty versus second fifty cases-70.2 ± 31.1 mins versus 56.5 ± 34.5 mins, P < 0.04). Qualitative evaluation revealed that Debakey forceps had ergonomic advantages over Kelly clamp. Conclusions. Debakey forceps crushing technique is safe and effective for liver parenchymal transection in all kinds of liver. Transection time improves with surgeon's experience. It has ergonomic advantages over Kelly clamp and is a better choice for liver transection.Entities:
Year: 2014 PMID: 25009367 PMCID: PMC4070417 DOI: 10.1155/2014/861829
Source DB: PubMed Journal: HPB Surg ISSN: 0894-8569
Indications of liver resection in the study.
| Indications | Numbers |
|---|---|
| Gallbladder cancer | 32 |
| Secondaries liver | 15 (colorectal-11, GIST-04) |
| Hydatid disease | 11 |
| Hilar cholangiocarcinoma | 09 |
| Hemangioma | 09 |
| Hepatocellular carcinoma | 08 (Child's A status) |
| Hepatoblastoma | 04 |
| Neuroendocrine tumor | 02 |
| Intrahepatic cholangiocarcinoma | 02 |
| FNH | 02 |
| Hamartoma | 02 |
| Recurrent pyogenic cholangitis | 01 |
| Hemangioendothelioma | 01 |
| Cancer hepatic flexure with local invasion of liver | 01 |
| Strictured hepaticojejunostomy with atrophy of right lobe liver with recurrent cholangitis | 01 |
| Total |
|
Types of liver resections.
| Type of resection | Numbers |
|---|---|
| Right hemihepatectomy | 19 |
| Right hemihepatectomy with segment I resection | 08 |
| Left hemihepatectomy | 09 |
| Left hemihepatectomy with segment I resection | 01 |
| Right trisectionectomy | 11 |
| Left lateral sectionectomy | 09 |
| Segment IVb V resection | 08 |
| Segments IV, V, and VI resection | 01 |
| Segments V, VI, and VII resection | 02 |
| Segments V and VI resection | 02 |
| Segment III resection | 01 |
| Segment V resection | 01 |
| Segment VI resection | 01 |
| Wedge resection for gallbladder cancer | 13 |
| Right posterior sectionectomy | 02 |
| Cystopericystectomy | 10 |
| Nonanatomical resection | 02 |
| Total |
|
Baseline characteristics in different groups.
| Characteristics | Group A | Group B | Group C | Group D |
|---|---|---|---|---|
| Sex | ||||
| Male (%) | 24 (45.28) | 8 (100) | 9 (64.29) | 20 (80) |
| Female (%) | 29 (54.72) | 0 (0.00) | 5 (35.71) | 5 (20) |
|
| ||||
| Underlying diseases (%) | ||||
| Hypertension | 7 (13.21) | 3 (37.50) | 1 (7.14) | 0 |
| DM | 4 (7.55) | 2 (25.00) | 0 | 2 (8.00) |
| COPD | 1 (1.89) | 3 (37.50) | 0 | 1 (4.00) |
| CAD | 0 | 0 | 0 | 0 |
Control: normal liver parenchyma.
CT: postchemotherapy.
Cholestatic: obstructive jaundice.
DM: diabetes mellitus.
COPD: chronic obstructive pulmonary disease.
CAD: coronary artery disease.
Comparison of age, transection time, total operative time, and postoperative hospital stay between four groups.
| Characteristics | Group A | Group B | Group C | Group D | A versus B | A versus C | A versus D |
| Age (years) | |||||||
| (Mean ± SD) | 48.94 ± 16.27 | 57.25 ± 11.38 | 48.46 ± 22.93 | 47.32 ± 13.69 | 0.91 | 0.59 | 0.44 |
| (Range) | 23–85 | 40–70 | 4–71 | 25–77 | |||
| Transection time (minutes) | |||||||
| (Mean ± SD) | 48.09 ± 20.07 | 130.38 ± 44.38 | 60.64 ± 32.81 | 75.8 ± 19.72 | 0.00 | 0.07 | 0.00 |
| (Median, IQR) | 48, 21 | 145, 69.5 | 52.5, 64 | 69, 18 | |||
| (Range) | 22–117 | 62–180 | 25–115 | 35–120 | |||
| Total operative time (minutes) | |||||||
| (Mean ± SD) | 110.41 ± 35.30 | 226.6 ± 57.8 | 145.21 ± 52.91 | 228.52 ± 43.20 | 0.00 | 0.004 | 0.00 |
| (Median, IQR) | 100, 32 | 218, 98.5 | 142.5, 94 | 209, 62 | |||
| (Range) | 68–252 | 150–310 | 75–230 | 152–308 | |||
| Hospital stay (days) | |||||||
| (Mean ± SD) | 6.72 ± 1.85 | 14.62 ± 5.50 | 10.07 ± 5.50 | 16.52 ± 5.11 | 0.00 | 0.0004 | 0.00 |
| (Median, IQR) | 7, 3 | 14.5, 5 | 9, 414 | 16, 6 | |||
| (Range) | 4–11 | 8–26 | 4–27 | 9–29 |
Control: normal liver parenchyma.
CT: postchemotherapy.
Cholestatic: obstructive jaundice.
Comparison of age, transection time, total operative time, and postoperative hospital stay in the first 50 and second 50 patients.
| Characteristics | Group 1 | Group 2 |
|
|---|---|---|---|
| First 50 patients | Second 50 patients | ||
| Age (years) | |||
| (Mean ± SD) | 48.08 ± 15.45 | 52.38 ± 17.44 | 0.52 |
| (Range) | 4–73 | 4.5–85 | |
| Transection time (minutes) | |||
| (Mean ± SD) | 70.2 ± 31.02 | 56.52 ± 34.54 | 0.039 |
| (Median, IQR) | 65, 33 | 50.5, 34 | |
| (Range) | 25–160 | 22–180 | |
| Total operative time (minutes) | |||
| (Mean ± SD) | 168.04 ± 66.50 | 140.20 ± 66.40 | 0.038 |
| (Median, IQR) | 155, 117 | 105, 100 | |
| (Range) | 68–305 | 74–310 | |
| Hospital stay (days) | |||
| (Mean ± SD) | 9.66 ± 5.40 | 10.88 ± 5.95 | 0.28 |
| (Median, IQR) | 8.5, 7 | 8, 7 | |
| (Range) | 4–29 | 5–27 |
Postoperative complications.
| Complication | Type of resection | Numbers | Disease |
|---|---|---|---|
| Bile leak | Left hemihepatectomy | 01 | Hydatid disease |
| Cystopericystectomy | 01 | Hydatid disease | |
| Right trisectionectomy | 01 | Gallbladder cancer | |
| Right hemihepatectomy plus segment I resection | 01 | Hilar cholangiocarcinoma | |
|
| |||
| Ascites | Right trisectionectomy | 04 | Gallbladder cancer |
| Left hemihepatectomy plus segment I | 01 | Hilar cholangiocarcinoma | |
| Right hemihepatectomy | 05 | HCC | |
|
| |||
| Wound infection | Left hemihepatectomy | 01 | Hydatid disease |
| Right trisectionectomy | 02 | Gallbladder cancer | |
| Right hemihepatectomy plus segment I | 01 | Hilar cholangiocarcinoma | |
| Right hemihepatectomy | 01 | HCC | |
|
| |||
| Hepatic encephalopathy* | Right hemihepatectomy | 01 | HCC |
|
| |||
| Postoperative liver failure* | Right trisectionectomy | 01 | Gallbladder cancer |
|
| |||
| DIC* | Right hemihepatectomy | 01 | Hepatoblastoma |
*Signifies mortality.
Figure 1Abnormal posture of wrist while using Kelly clamp.
Figure 8More inward position of Debakey forceps with neutral posture of wrist.
Figure 2Neutral posture of wrist while using Debakey forceps.
Figure 6Position of Debakey forceps with neutral posture of wrist.
Figure 7Inward position of Debakey forceps with neutral posture of wrist.
Figure 3Position of Kelly clamp with neutral posture of wrist.
Figure 4Position of Kelly clamp with slight flexion of wrist.
Figure 5Functional position of Kelly clamp with awkward posture of wrist.